August 9, 2012
Shionogi & Co. announced on August 8 that Seoul-based Ildong Pharmaceutical, the company’s business partner in South Korea, received approval on July 31 for the idiopathic pulmonary fibrosis treatment Pirespa 200 mg tablets (pirfenidone). Shionogi signed a licensing agreement with...read more